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History of Surgery Lecture 
Bert Myburgh, MB, ChM, FRCS, DSc, FACS (Hon) 
Johannesburgh, South Africa 
I read with great interest and enjoyment Dr Starzl's ex-
cellent Charles Drake History of Surgery Lecture. 1 I 
wish to endorse strongly, on the basis of our experimen-
tal work with tolerogenesis in the baboon (Papio ursinus) 
kidney transplant model, the two principles of tolero-
genic immunosuppression he derived from historical 
observations, namely pretreatment and the importance 
of limiting posttransplant immunosuppression. 
In many hundreds of experiments we demonstrated 
consistently the ability of a modified regimen of pre-
transplant total lymphoid irradiation (TIl) to induce 
durable (greater than 10 years survival with normal graft 
function) and donor-specific transplantation tolerance 
in baboon kidney and liver transplantation, without the 
use of any posnransplant immunosuppressive treat-
ment. The most effective TLI protocol obtained con-
sisted of a total dose of 800 cGy given in 80- or 100-cGy 
fractions twice a week to a wide field. Tolerance occurred 
in one-third to one-half of many groups studied.2-4 
In efforts to increase the tolerant fraction obtained we 
studied the effect of adding posttransplant immunosup-
pressive drug therapy to the pretransplant TLI regimen. 
With even limited 2-week courses of cyclosporine A, 
prednisone, or antilymphocyte globulin, there was ei-
ther no additive effect in terms of tolerance production, 
or, in the case of cyclosporine A, a counterproductive 
effect. 3 Even more dramatic was the effect of adding only 
two fractions of 100 cGy each in the second and third 
weeks after transplantation. Graft survival was drasti-
cally shortened and tolerance induction was abrogated. 5 
We interpreted these findings as indicating that an 
active mechanism or mechanisms, capable of inhibition 
by immunosuppressive measures, were involved the pro-
cess of tolerance induction. We were able to demonstrate 
a marked increase in activated T cells and of usually 
nonspecific suppressor cells in the circulation of these 
tolerant baboons soon after transplantation. 6.7 
These findings also probably explain why we did not 
achieve the same results in terms of full tolerance pro-
duction with pretransplant TLI in 73 kidney transplan-
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tation patients. 8 For ethical reasons, as a result of the 
unpredictability of tolerance production in individual 
baboons, all our patients received fairly conventional 
doses of posttransplant immunosuppressive drugs. 
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Reply 
Thomas E Starzl, MD, PhD, FACS, 
Noriko Murase, MD 
Pittsburgh, PA 
We enthusiastically acknowledge the magnificent stud-
ies of total lymphoid irradiation (TLI) by Myburgh in 
baboon transplant models, beginning more than a quar-
ter of a century ago. The radiotherapy regimen known as 
TLI had been developed by Henry Kaplan at Stanford 
for the treatment of human malignant lymphomas, 1 and 
was known to be immunosuppressive. 2 Because the TLI 
spared part of the central lymphoid organ system, it did 
not cause leukopenia or other overt myel 0 toxicity. Also 
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at Stanford, Slavin and Strober and colleagues3.-i had 
induced specific rolerance to skin and heans of inbred 
adult mice and rats using a combination of TLI and 
donor-specific bone marrow. Unlike the outcomes in 
classic experiments in which total-body irradiation was 
used to destroy the host immune system before bone 
marrow cell infusion,5.0 the engrafted allogeneic bone 
marrow did not cause graft-versus-host-disease 
(GVHD) in the rodents. 3A 
In their series of brilliant experiments, Myburgh and 
coworkers7.s confirmed these findings in baboons after 
kidney and liver allotransplantation. Eventually, five 
clinical trials with TLI were conducted. These were car-
ried out at Stanford, the University of Minnesota, Lou-
vain, and Rome Universities,9.'2 and by Myburgh at the 
Witwatersrand University in Johannesburg. 13• '4 All ex-
cept the South African patients (some of whom were 
liver recipients) underwent renal transplantation exclu-
sively. The results were summarized by Myburgh at the 
Transplantation Society congress in August 1988.13 His 
repon revealed a striking change in therapeutic inten-
tion in the course of the trials. The change had been 
foreshadowed by new laboratory experiments showing 
that, on the average, TLI without bone marrow was as 
effective as the combined modalities. 13•15 Consequently, 
bone marrow was omitted altogether in the TLI-ueated 
patients of Stanford (n = 25), Louvain (n = 20), and 
Rome (n = 30), and was used only occasionally in Min-
neapolis (5 of22) or with decreasing frequency in Johan-
nesburg (number unstipulated but known to include 
liver recipients). 
TLI had become a competitor by the 1980s with the 
new drug, cyclosporine, as a primary immunosuppres-
sant, rather than being viewed as a means to the end of 
establishing tolerance through bone marrow chimerism. 
Because of its inconvenience, expense, and morbidity, 
TLI lost the race. What was left when the smoke cleared 
was a group of surviving organ recipients in each of the 
clinical series with thoroughly documented donor-
specific allogeneic tolerance. Because most of these pa-
tients did not have bone marrow infusion, organ graft 
acceptance was explained with different multifactorial 
lwpotheses, all chimerism-exclusionary. With the hind-
sight that began to emerge with the discovery that long-
sunriving organ recipients did have low-level donor leu-
kocyte chimerism, IG. 17 it was possible to understand how 
organs transplanted under nonspecific immunosuppres-
sion could sometimes induce the same kind ot'drug-free 
J Am Call Surg 
tolerance as that of the cyroreduced or cyroablated bone 
marrow recipient. The earlier enigmacic observation 
made by Myburgh thac immunosuppression could be 
tolerogenic also could be explained as in (he Charles G 
Drake Lecture. 18 
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Postthyroidectomy Hypocalcemia 
Chung-Yau Lo, MBBS (HK), MS (HK), FRCS (Edin), FACS 
Hong Kong, China 
I read with interest, in the OctOber 2002 issue of this 
journal, the article by Dr Abboud and coworkers] con-
cermng risk factors for postthyroidectomy 
hypocalcemia. 
Postoperative evolution of serum calcium levels is not 
a response that is specific to thyroid surgery but also 
occurs after other noncervical operations of a similar 
magnitude such as herniorrhaphy. Z Postoperative symp-
tomatic hypocalcemia is believed to be a multifactorial 
phenomenon attributed to hypoparathyroidism. This 
phenomenon is seen only after bilateral thyroidecto-
mies, but almost never after unilateral lobectomies un-
less the patient had previous thyroid operations. Al-
though a decline in serum calcium levels will be 
observed, this should not be associated with hypocalce-
mic symptoms. Routine serum calcium monitoring 
should be reserved for patients who have undergone ei-
ther bilateral or completion thyroidectomy and who 
otherwise might be at risk of symptOmatic hypocalce-
mia. So the practice of routine postoperative calcium 
monitoring for patients who undergo unilateral thyroid 
operations, as was performed in this study, is not cost-
effective and should be abandoned. 
It has been suggested that a program of routine cal-
cium supplementation should be the future basis for 
same-day or I-day admission after bilateral or extensive 
thyroid operations. 3 But, the relatively infrequent occur-
rence of postoperative hypocalcemia suggests that rou-
tine treatment is probably not cost-effective, and can 
hinder the detection of Hue hypocalcemia. 4 During the 
risk factor analysis of the present article, the inclusion of 
patients who underwent unilateral thyroid lobectomy in 
the absence of previous thvroidectomy seems, therefore, 
inappropriate. There is no doubt that a bilateral thyroid-
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ectomy is readily identifiable as an independent risk fac-
tor for postthyroidectomy hypocalcemia. Recommend-
ing oral calcium supplementation for patients after 
bilateral thyroidectomy based on such analysis is not 
cost-effective and can be misleading. 
This study also mentioned that patients with thyrotoxi-
cosis were treated by a standard protocol with a combina-
tion of methimazole and propranolol until they became 
biochemically euthyroid. It is surprising, therdore, to ob-
serve a substantial number of patients with hyperthyroid 
function during the subsequent analysis, and that an ele-
vated thyroxine level was identified as an independent risk 
factor for postthyroidectomy hypocalcemia. Perhaps the 
authors were referring to the underlying pathologies lead-
ing to thyrotoxicosis rather than the presence of m elevated 
thyroxine level before the operation. 
We do, however, agree with the authors that patients 
who undergo parathyroid autotransplantations have an 
increased risk of developing postoperative hypocalce-
mia.s But a parathyroid autotransplantation could pre-
vent the occurrence of permanent hypoparathyroidism 
for those patients who developed postoperative hypo cal-
cemia. 5 Unfortunately, no data were shown on the 
follow-up status of patients in the present study to con-
firm either longterm outcomes or the correlation be-
tween patient outcomes and the type of hypoparathy-
roidism observed. Identification of parathyroid 
autotransplantation as an independent risk factor for 
postthyroidectomy hypocalcemia can be misleading 
without documentation of its role in preventing perma-
nent hypoparathyroidism. 
Clinical risk factors for post-thyroidectomy hypocal-
cemia can help the operating surgeon identify high-risk 
patients who warrant close monitoring of their serum 
calcium levels or for whom early calcium supplementa-
tion is recommended. But close monitoring of serum 
calcium levels is the standard practice adopted to iden-
tify postthyroidectomy hypocalcemia from parathyroid 
insufficiency. Concerns over the possible development 
of postoperative hypocalcemia secondary to hypopara-
thyroidism have prolonged the duration of hospitaliza-
tion for patients who would otherwise be considered for 
early discharge. Efforts are also being made to use spe-
cific monitoring tools to identify individual patients 
who are at risk of developing postthyroidectomy hy-
pocalcemia during the postoperative period. Early con-
secutive calcium monitoring has been used to identify 
patients at risk of clinically significant hypocalcemia. 4.6 
